Diphtheria, tetanus, pertussis and polio vaccines for adults
The vaccine is for the prevention of whooping cough, diphtheria, tetanus and poliomyelitis (polio) in adults.

Medicover
- Vaccine description
- Important information
- Purchase step-by-step
- Documents
What does the product contain?
The vaccine contains a reduced dose of diphtheria toxoid, tetanus toxoid, a reduced dose of cell-free pertussis antigens and inactivated poliovirus. The purpose of vaccination is to induce an immune response. The vaccine is intended for use as a booster.
Who is the vaccine for?
Immunisation against whooping cough is particularly important for people who have or will have contact with newborn babies and young children:
- women who are planning a pregnancy and their partners,
- parents,
- older siblings,
- grandparents,
- caregivers.
Vaccinating household members and other caregivers can protect young children who are not yet immunised from catching dangerous infections from those around them. Vaccinating these people is part of the so-called cocoon strategy.
It is important to stress the importance of pertussis vaccination at this time when we have an unstable epidemiological situation and an increase in the incidence of pertussis.
The vaccine is also used to provide passive protection against pertussis in newborns and children in early infancy, after the mother has been vaccinated during pregnancy (week 28-36 of gestation).
What are the effects of the vaccine?
- Immunity against infection with up to 4 diseases (tetanus, whooping cough, diphtheria and polio);
- Passive protection of newborns and infants against whooping cough if a woman has been vaccinated during pregnancy.
The vaccine can be given with other preparations: inactivated influenza vaccine, hepatitis B vaccine, inactivated human papillomavirus (HPV) vaccine.
In the absence of a diphtheria, tetanus and pertussis (DTP) vaccine on the market, pregnant women may receive the diphtheria, tetanus, pertussis and poliomyelitis vaccine.